-
1
-
-
0035749812
-
Oxidative stress and diabetic cardiomyopathy: A brief review
-
DOI 10.1385/CT:1:3:181
-
Oxidative stress and diabetic cardiomyopathy: a brief review. Cai L, Kang YJ, Cardiovasc Toxicol 2001 1 3 181 193 10.1385/CT:1:3:181 12213971 (Pubitemid 37013746)
-
(2001)
Cardiovascular Toxicology
, vol.1
, Issue.3
, pp. 181-193
-
-
Cai, L.1
Kang, Y.J.2
-
2
-
-
65449151412
-
Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials
-
10.1038/nrd2476 19404313
-
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Calcutt NA, Cooper ME, Kern TS, Schmidt AM, Nat Rev Drug Discov 2009 8 5 417 429 10.1038/nrd2476 19404313
-
(2009)
Nat Rev Drug Discov
, vol.8
, Issue.5
, pp. 417-429
-
-
Calcutt, N.A.1
Cooper, M.E.2
Kern, T.S.3
Schmidt, A.M.4
-
3
-
-
8644267972
-
Hyperglycemia-induced oxidative stress in diabetic complications
-
DOI 10.1007/s00418-004-0678-9
-
Hyperglycemia-induced oxidative stress in diabetic complications. King GL, Loeken MR, Histochem Cell Biol 2004 122 4 333 338 10.1007/s00418-004-0678-9 15257460 (Pubitemid 39506591)
-
(2004)
Histochemistry and Cell Biology
, vol.122
, Issue.4
, pp. 333-338
-
-
King, G.L.1
Loeken, M.R.2
-
4
-
-
84855174417
-
New perspectives on diabetic vascular complications: The loss of endogenous protective factors induced by hyperglycemia
-
10.4093/dmj.2011.35.1.8 21537407
-
New perspectives on diabetic vascular complications: the loss of endogenous protective factors induced by hyperglycemia. Jeong IK, King GL, Diabetes Metab J 2011 35 1 8 11 10.4093/dmj.2011.35.1.8 21537407
-
(2011)
Diabetes Metab J
, vol.35
, Issue.1
, pp. 8-11
-
-
Jeong, I.K.1
King, G.L.2
-
5
-
-
84857082515
-
The role of oxidative stress and antioxidants in diabetic complications
-
22375253
-
The role of oxidative stress and antioxidants in diabetic complications. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J, Sultan Qaboos Univ Med J 2012 12 1 5 18 22375253
-
(2012)
Sultan Qaboos Univ Med J
, vol.12
, Issue.1
, pp. 5-18
-
-
Matough, F.A.1
Budin, S.B.2
Hamid, Z.A.3
Alwahaibi, N.4
Mohamed, J.5
-
6
-
-
35348893135
-
Diabetic cardiomyopathy and its prevention by metallothionein: Experimental evidence, possible mechanisms and clinical implications
-
DOI 10.2174/092986707781389646
-
Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications. Cai L, Curr Med Chem 2007 14 20 2193 2203 17691957 (Pubitemid 47578157)
-
(2007)
Current Medicinal Chemistry
, vol.14
, Issue.20
, pp. 2193-2203
-
-
Cai, L.1
-
7
-
-
79851508187
-
The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation
-
10.1097/MCO.0b013e32834136f2 21102319
-
The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D, Curr Opin Clin Nutr Metab Care 2011 14 1 41 48 10.1097/MCO.0b013e32834136f2 21102319
-
(2011)
Curr Opin Clin Nutr Metab Care
, vol.14
, Issue.1
, pp. 41-48
-
-
Sykiotis, G.P.1
Habeos, I.G.2
Samuelson, A.V.3
Bohmann, D.4
-
8
-
-
0037821802
-
Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression
-
DOI 10.1074/jbc.M300931200
-
Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. McMahon M, Itoh K, Yamamoto M, Hayes JD, J Biol Chem 2003 278 24 21592 21600 10.1074/jbc.M300931200 12682069 (Pubitemid 36792558)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.24
, pp. 21592-21600
-
-
McMahon, M.1
Itoh, K.2
Yamamoto, M.3
Hayes, J.D.4
-
9
-
-
84862278246
-
Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge
-
22685617
-
Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge. Donovan EL, McCord JM, Reuland DJ, Miller BF, Hamilton KL, Oxid Med Cell Longev 2012 2012 132931 22685617
-
(2012)
Oxid Med Cell Longev
, vol.2012
, pp. 132931
-
-
Donovan, E.L.1
McCord, J.M.2
Reuland, D.J.3
Miller, B.F.4
Hamilton, K.L.5
-
10
-
-
80755168955
-
Nrf2 activators as attractive therapeutics for diabetic nephropathy
-
10.2337/db11-1072 22025774
-
Nrf2 activators as attractive therapeutics for diabetic nephropathy. de Haan JB, Diabetes 2011 60 11 2683 2684 10.2337/db11-1072 22025774
-
(2011)
Diabetes
, vol.60
, Issue.11
, pp. 2683-2684
-
-
De Haan, J.B.1
-
11
-
-
84862282913
-
Prevention of diabetic complications by activation of nrf2: Diabetic cardiomyopathy and nephropathy
-
22645602
-
Prevention of diabetic complications by activation of nrf2: diabetic cardiomyopathy and nephropathy. Li B, Liu S, Miao L, Cai L, Exp Diabetes Res 2012 2012 216512 22645602
-
(2012)
Exp Diabetes Res
, vol.2012
, pp. 216512
-
-
Li, B.1
Liu, S.2
Miao, L.3
Cai, L.4
-
12
-
-
0032841203
-
Antioxidant functions of sulforaphane: A potent inducer of phase II detoxication enzymes
-
DOI 10.1016/S0278-6915(99)00082-4, PII S0278691599000824
-
Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Fahey JW, Talalay P, Food Chem Toxicol 1999 37 9-10 973 979 10541453 (Pubitemid 29481800)
-
(1999)
Food and Chemical Toxicology
, vol.37
, Issue.9-10
, pp. 973-979
-
-
Fahey, J.W.1
Talalay, P.2
-
13
-
-
20044362943
-
Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy
-
DOI 10.2337/diabetes.54.6.1829
-
Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Cai L, Wang J, Li Y, Sun X, Wang L, Zhou Z, Kang YJ, Diabetes 2005 54 6 1829 1837 10.2337/diabetes.54.6.1829 15919806 (Pubitemid 40770774)
-
(2005)
Diabetes
, vol.54
, Issue.6
, pp. 1829-1837
-
-
Cai, L.1
Wang, J.2
Li, Y.3
Sun, X.4
Wang, L.5
Zhou, Z.6
Kang, Y.J.7
-
14
-
-
84860447071
-
Protective effect of sulforaphane against oxidative stress: Recent advances
-
10.1016/j.etp.2010.11.005 21129940
-
Protective effect of sulforaphane against oxidative stress: recent advances. Guerrero-Beltran CE, Calderon-Oliver M, Pedraza-Chaverri J, Chirino YI, Exp Toxicol Pathol 2012 64 5 503 508 10.1016/j.etp.2010.11.005 21129940
-
(2012)
Exp Toxicol Pathol
, vol.64
, Issue.5
, pp. 503-508
-
-
Guerrero-Beltran, C.E.1
Calderon-Oliver, M.2
Pedraza-Chaverri, J.3
Chirino, Y.I.4
-
15
-
-
33749513188
-
Attenuation by Metallothionein of Early Cardiac Cell Death via Suppression of Mitochondrial Oxidative Stress Results in a Prevention of Diabetic Cardiomyopathy
-
DOI 10.1016/j.jacc.2006.07.022, PII S0735109706019097
-
Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ, J Am Coll Cardiol 2006 48 8 1688 1697 17045908 (Pubitemid 44528172)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.8
, pp. 1688-1697
-
-
Cai, L.1
Wang, Y.2
Zhou, G.3
Chen, T.4
Song, Y.5
Li, X.6
Kang, Y.J.7
-
16
-
-
79955634116
-
Resveratrol protects diabetic kidney by attenuating hyperglycemia- mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling
-
10.1016/j.bbadis.2011.03.008 21439372
-
Resveratrol protects diabetic kidney by attenuating hyperglycemia- mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Palsamy P, Subramanian S, Biochim Biophys Acta 2011 1812 7 719 731 10.1016/j.bbadis.2011.03.008 21439372
-
(2011)
Biochim Biophys Acta
, vol.1812
, Issue.7
, pp. 719-731
-
-
Palsamy, P.1
Subramanian, S.2
-
17
-
-
79551575483
-
Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo
-
10.2337/db10-1164 21270272
-
Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Tan Y, Ichikawa T, Li J, Si Q, Yang H, Chen X, Goldblatt CS, Meyer CJ, Li X, Cai L, et al. Diabetes 2011 60 2 625 633 10.2337/db10-1164 21270272
-
(2011)
Diabetes
, vol.60
, Issue.2
, pp. 625-633
-
-
Tan, Y.1
Ichikawa, T.2
Li, J.3
Si, Q.4
Yang, H.5
Chen, X.6
Goldblatt, C.S.7
Meyer, C.J.8
Li, X.9
Cai, L.10
-
18
-
-
80255126225
-
Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress
-
10.1016/j.freeradbiomed.2011.09.007 21964506
-
Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Yang YC, Lii CK, Lin AH, Yeh YW, Yao HT, Li CC, Liu KL, Chen HW, Free Radic Biol Med 2011 51 11 2073 2081 10.1016/j.freeradbiomed. 2011.09.007 21964506
-
(2011)
Free Radic Biol Med
, vol.51
, Issue.11
, pp. 2073-2081
-
-
Yang, Y.C.1
Lii, C.K.2
Lin, A.H.3
Yeh, Y.W.4
Yao, H.T.5
Li, C.C.6
Liu, K.L.7
Chen, H.W.8
-
19
-
-
79961043903
-
Vascular oxidative stress in aging: A homeostatic failure due to dysregulation of NRF2-mediated antioxidant response
-
10.1152/ajpheart.01134.2010 21602469
-
Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response. Ungvari Z, Bailey-Downs L, Sosnowska D, Gautam T, Koncz P, Losonczy G, Ballabh P, de Cabo R, Sonntag WE, Csiszar A, Am J Physiol Heart Circ Physiol 2011 301 2 363 H372 10.1152/ajpheart.01134.2010 21602469
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
, Issue.2
-
-
Ungvari, Z.1
Bailey-Downs, L.2
Sosnowska, D.3
Gautam, T.4
Koncz, P.5
Losonczy, G.6
Ballabh, P.7
De Cabo, R.8
Sonntag, W.E.9
Csiszar, A.10
-
20
-
-
79955068967
-
Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia
-
10.1152/ajpheart.00402.2010 21217061
-
Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Ungvari Z, Bailey-Downs L, Gautam T, Jimenez R, Losonczy G, Zhang C, Ballabh P, Recchia FA, Wilkerson DC, Sonntag WE, et al. Am J Physiol Heart Circ Physiol 2011 300 4 1133 H1140 10.1152/ajpheart.00402.2010 21217061
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.300
, Issue.4
-
-
Ungvari, Z.1
Bailey-Downs, L.2
Gautam, T.3
Jimenez, R.4
Losonczy, G.5
Zhang, C.6
Ballabh, P.7
Recchia, F.A.8
Wilkerson, D.C.9
Sonntag, W.E.10
-
21
-
-
77649163840
-
Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice
-
10.1371/journal.pone.0008579 20062804
-
Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. Yu S, Khor TO, Cheung KL, Li W, Wu TY, Huang Y, Foster BA, Kan YW, Kong AN, PLoS One 2010 5 1 8579 10.1371/journal.pone.0008579 20062804
-
(2010)
PLoS One
, vol.5
, Issue.1
, pp. 58579
-
-
Yu, S.1
Khor, T.O.2
Cheung, K.L.3
Li, W.4
Wu, T.Y.5
Huang, Y.6
Foster, B.A.7
Kan, Y.W.8
Kong, A.N.9
-
22
-
-
80053978389
-
Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation
-
10.1016/j.bcp.2011.07.065 21787756
-
Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Khor TO, Huang Y, Wu TY, Shu L, Lee J, Kong AN, Biochem Pharmacol 2011 82 9 1073 1078 10.1016/j.bcp.2011.07.065 21787756
-
(2011)
Biochem Pharmacol
, vol.82
, Issue.9
, pp. 1073-1078
-
-
Khor, T.O.1
Huang, Y.2
Wu, T.Y.3
Shu, L.4
Lee, J.5
Kong, A.N.6
-
23
-
-
84862074144
-
A gamma-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation
-
10.3945/jn.111.153114 22457388
-
A gamma-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation. Huang Y, Khor TO, Shu L, Saw CL, Wu TY, Suh N, Yang CS, Kong AN, J Nutr 2012 142 5 818 823 10.3945/jn.111.153114 22457388
-
(2012)
J Nutr
, vol.142
, Issue.5
, pp. 818-823
-
-
Huang, Y.1
Khor, T.O.2
Shu, L.3
Saw, C.L.4
Wu, T.Y.5
Suh, N.6
Yang, C.S.7
Kong, A.N.8
-
24
-
-
84869082989
-
Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells
-
10.1186/1868-7083-3-3 22303414
-
Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Hsu A, Wong CP, Yu Z, Williams DE, Dashwood RH, Ho E, Clin Epigenetics 2011 3 3 10.1186/1868-7083-3-3 22303414
-
(2011)
Clin Epigenetics
, vol.3
, pp. 3
-
-
Hsu, A.1
Wong, C.P.2
Yu, Z.3
Williams, D.E.4
Dashwood, R.H.5
Ho, E.6
|